Literature DB >> 26549446

Interneuronal Nitric Oxide Signaling Mediates Post-synaptic Long-Term Depression of Striatal Glutamatergic Synapses.

Igor V Rafalovich1, Alexandria E Melendez1, Joshua L Plotkin2, Asami Tanimura1, Shenyu Zhai1, D James Surmeier3.   

Abstract

Experience-driven plasticity of glutamatergic synapses on striatal spiny projection neurons (SPNs) is thought to be essential to goal-directed behavior and habit formation. One major form of striatal plasticity, long-term depression (LTD), has long appeared to be expressed only pre-synaptically. Contrary to this view, nitric oxide (NO) generated by striatal interneurons was found to induce a post-synaptically expressed form of LTD at SPN glutamatergic synapses. This form of LTD was dependent on signaling through guanylyl cyclase and protein kinase G, both of which are abundantly expressed by SPNs. NO-LTD was unaffected by local synaptic activity or antagonism of endocannabinoid (eCb) and dopamine receptors, all of which modulate canonical, pre-synaptic LTD. Moreover, NO signaling disrupted induction of this canonical LTD by inhibiting dendritic Ca(2+) channels regulating eCb synthesis. These results establish an interneuron-dependent, heterosynaptic form of post-synaptic LTD that could act to promote stability of the striatal network during learning.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26549446      PMCID: PMC4864038          DOI: 10.1016/j.celrep.2015.10.015

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  42 in total

Review 1.  Nitric oxide and memory.

Authors:  Abraham J Susswein; Ayelet Katzoff; Nimrod Miller; Itay Hurwitz
Journal:  Neuroscientist       Date:  2004-04       Impact factor: 7.519

Review 2.  Permissive role of interneurons in corticostriatal synaptic plasticity.

Authors:  D Centonze; P Gubellini; G Bernardi; P Calabresi
Journal:  Brain Res Brain Res Rev       Date:  1999-12

3.  Equal sensitivity of Cav1.2 and Cav1.3 channels to the opposing modulations of PKA and PKG in mouse chromaffin cells.

Authors:  Satyajit Mahapatra; Andrea Marcantoni; Annalisa Zuccotti; Valentina Carabelli; Emilio Carbone
Journal:  J Physiol       Date:  2012-07-23       Impact factor: 5.182

4.  Localization of nitric oxide synthase indicating a neural role for nitric oxide.

Authors:  D S Bredt; P M Hwang; S H Snyder
Journal:  Nature       Date:  1990-10-25       Impact factor: 49.962

Review 5.  The use of nitric oxide donors in pharmacological studies.

Authors:  M Feelisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1998-07       Impact factor: 3.000

Review 6.  Dopamine and synaptic plasticity in dorsal striatal circuits controlling action selection.

Authors:  D James Surmeier; Joshua Plotkin; Weixing Shen
Journal:  Curr Opin Neurobiol       Date:  2009-11-05       Impact factor: 6.627

7.  Opioids block long-term potentiation of inhibitory synapses.

Authors:  Fereshteh S Nugent; Esther C Penick; Julie A Kauer
Journal:  Nature       Date:  2007-04-26       Impact factor: 49.962

8.  Endocannabinoid-dependent plasticity at GABAergic and glutamatergic synapses in the striatum is regulated by synaptic activity.

Authors:  Louise Adermark; Giuseppe Talani; David M Lovinger
Journal:  Eur J Neurosci       Date:  2009-01       Impact factor: 3.386

9.  Short- and long-term synaptic depression in rat neostriatum.

Authors:  D M Lovinger; E C Tyler; A Merritt
Journal:  J Neurophysiol       Date:  1993-11       Impact factor: 2.714

Review 10.  Concepts of neural nitric oxide-mediated transmission.

Authors:  John Garthwaite
Journal:  Eur J Neurosci       Date:  2008-06       Impact factor: 3.386

View more
  13 in total

Review 1.  Dopaminergic modulation of striatal function and Parkinson's disease.

Authors:  Shenyu Zhai; Weixing Shen; Steven M Graves; D James Surmeier
Journal:  J Neural Transm (Vienna)       Date:  2019-04-01       Impact factor: 3.575

Review 2.  Striatal synapses, circuits, and Parkinson's disease.

Authors:  Shenyu Zhai; Asami Tanimura; Steven M Graves; Weixing Shen; D James Surmeier
Journal:  Curr Opin Neurobiol       Date:  2017-08-24       Impact factor: 6.627

3.  Learning new sequential stepping patterns requires striatal plasticity during the earliest phase of acquisition.

Authors:  Toru Nakamura; Masatoshi Nagata; Takeshi Yagi; Ann M Graybiel; Tetsuo Yamamori; Takashi Kitsukawa
Journal:  Eur J Neurosci       Date:  2017-02-27       Impact factor: 3.386

Review 4.  Dysfunction of the corticostriatal pathway in autism spectrum disorders.

Authors:  Wei Li; Lucas Pozzo-Miller
Journal:  J Neurosci Res       Date:  2019-11-22       Impact factor: 4.164

5.  Pathway-Specific Remodeling of Thalamostriatal Synapses in a Mouse Model of Parkinson's Disease.

Authors:  Asami Tanimura; Weixing Shen; David Wokosin; D James Surmeier
Journal:  Mov Disord       Date:  2022-04-29       Impact factor: 9.698

Review 6.  Striatal synaptic adaptations in Parkinson's disease.

Authors:  Weixing Shen; Shenyu Zhai; D James Surmeier
Journal:  Neurobiol Dis       Date:  2022-03-08       Impact factor: 7.046

7.  Dichotomous Effects of Mu Opioid Receptor Activation on Striatal Low-Threshold Spike Interneurons.

Authors:  Rasha Elghaba; Enrico Bracci
Journal:  Front Cell Neurosci       Date:  2017-12-05       Impact factor: 5.505

8.  Differential processing of thalamic information via distinct striatal interneuron circuits.

Authors:  Maxime Assous; Jaime Kaminer; Fulva Shah; Arpan Garg; Tibor Koós; James M Tepper
Journal:  Nat Commun       Date:  2017-06-12       Impact factor: 14.919

9.  Mutual Control of Cholinergic and Low-Threshold Spike Interneurons in the Striatum.

Authors:  Rasha Elghaba; Nicolas Vautrelle; Enrico Bracci
Journal:  Front Cell Neurosci       Date:  2016-04-29       Impact factor: 5.505

10.  Thinking Outside the Box (and Arrow): Current Themes in Striatal Dysfunction in Movement Disorders.

Authors:  Joshua L Plotkin; Joshua A Goldberg
Journal:  Neuroscientist       Date:  2018-10-31       Impact factor: 7.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.